Press Release

Collection Sites Announces Agreement to Offer COVID-19 Testing Services and Protocols for The Elf On The Shelf’s Magical Holiday Journey

Toronto, Ontario November 11, 2020 — QuestCap Inc. (“QuestCap” or the “Company”) (NEO:QSC; OTC:COPRF; FRA:34C1), through its wholly-owned subsidiary, Collection Sites, LLC has signed a binding letter of intent with Elf Attractions LLC, the producer of The Elf on the Shelf’s Magical Holiday Journey, to implement COVID-19 testing protocols for event employees. Elf Attractions LLC, a joint venture between Constellation Immersive and DeepDreem IM, produces The Elf on the Shelf-themed attractions in association with The Lumistella Company, creators and owners of The Elf on the Shelf intellectual property.

Collection Sites will coordinate COVID-19 testing for over 70 event-related employees to help ensure people can safely enjoy a holiday experience during the pandemic. The event is an immersive drive-through spectacle that draws on The Elf on the Shelf intellectual property and includes original music, performances, light displays, and more. It will take place in Pomona, California over an 8-week period starting November 12th and is expected to welcome over 100,000 people. The Elf On The Shelf has a large fan base with 17 million monthly website page views, 3.8+ million app downloads, and 2.5+ million social media followers.

“With the holiday season upon us, we are extremely excited to be able to work with Elf Attractions to ensure The Elf on the Shelf’s Magical Holiday Journey will be a safe and exciting spectacle for all,” stated Mr. Doug Sommerville, CEO of QuestCap. “The Collection Sites team is striving to be the leader in convenient and effective COVID-19 testing. They are focused on helping Americans and business return to normal life by making testing a normal routine for everyone, and helping Elf Attractions put on an event in this new COVID environment is a perfect example of how we can restore reality responsibly.”

The COVID-19 testing and operating protocols have been developed by Dr. Glenn Copeland and Dr. Lawrence Steinman, medical experts and QuestCap advisors, who will help ensure the safety of employees and, by extension, event-goers. The protocols consist of digital temperature checks, symptom questionnaires, and a suite of COVID-19 testing along with social distancing and proper recording and reporting for contact tracing purposes.   

“By working with Collection Sites to implement proper testing protocols for our employees, we can keep the Christmas spirit alive and deliver a safe event for employees and customers,” says Marty LaSalle, Co-Head of Constellation Immersive. “Through their previous testing partnerships, Collection Sites has demonstrated their ability to help safely operate businesses and we are excited to be working with them this holiday season.”

About Constellation Immersive

Constellation Immersive is an experience-based producing studio specializing in original content. The company collaborates with world class talent and iconic brands to create inspiring spaces at the convergence of pop culture, storytelling, design and technology.

About QuestCap Inc.

QuestCap Inc. (NEO:QSC; OTC:COPRF; FRA:34C1)  seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, QuestCap offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment.

QuestCap has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space.  This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine.

QuestCap’s primary focus is the sale of COVID-19 IgG/IgM antibody tests authorized by FDA under an EUA for use by authorized laboratories. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments handled through the online portal Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.

For more info on The Elf on the Shelf’s Magical Holiday Journey, please visit

For additional information, please contact:
Doug Sommerville, CEO

For investing inquiries please contact:
Evan Veryard

For US media inquiries please contact:
Veronica Welch

For Elf on the Shelf media inquiries please contact:

John Filizzola

Cautionary Note Regarding Forward-looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the letter of intent among Collection Sites LLC and Elf Attractions, LLC. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.